Technologically Advanced Solution For Peripheral Artery Disease Treatment Industry Trends Gaining Momentum in the Global Peripheral Artery Disease Market

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

Peripheral Artery Disease Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
The market size of peripheral artery disease has witnessed considerable growth over the past few years. It is expected to expand from $4.31 billion in 2024 to $4.63 billion in 2025, yielding a compound annual growth rate (CAGR) of 7.5%. Factors contributing to the growth during the historical period include increasing incidence of risk contributors, rise of the geriatric population, advancements in clinical research and evidence-based medicine, awareness and screening initiatives, as well as governmental healare programs.

Peripheral Artery Disease Market Size Forecast: What's the Projected Valuation by 2029?
Over the coming years, the peripheral artery disease market looks set to experience a robust growth, with a projected increase to $6.23 billion in 2029 and a compound annual growth rate (CAGR) of 7.7%. Factors contributing to this predicted development during the forecast period include an emphasis on patient-centered healare, the continuous evolution of minimally invasive techniques, the rise of digital healare and remote patient monitoring, the adoption of regenerative medicinal strategies, and the use of precision drug treatments. The key trends for the forecast period include health equality initiatives, the incorporation of wearable technology, the growth of home-based rehabilitation programs, patient-led healare outcomes, and the transition towards outpatient care.

View the full report here:
https://www.thebusinessresearchcompany.com/report/peripheral-artery-disease-global-market-report

What Are the Drivers Transforming the Peripheral Artery Disease Market?
The peripheral artery disease market is anticipated to grow due to the increasing incidence of peripheral artery diseases. Such diseases involve the constriction or obstruction of arteries outside the heart, most commonly in the legs. This can lead to decreased blood flow and possible complications. Treatments for peripheral artery disease aim to alleviate symptoms, improve mobility, and lessen the chance of serious complications, thereby improving patient quality of life. The American Heart Association, a non-profit organization based in the U.S., estimated in June 2023 that between 7 to 12 million people in the U.S., and approximately 200 million individuals worldwide, are affected by this condition. Consequently, this escalating prevalence of peripheral artery diseases is propelling the expansion of the peripheral artery disease market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12068&type=smp

What Long-Term Trends Will Define the Future of the Peripheral Artery Disease Market?
Technological innovations are emerging as a dominant trend in the peripheral artery disease market. Prominent firms in the market are leveraging cutting-edge surgical treatments to maintain a firm footing. Take, for example, the Singapore-based Genesis MedTech Group, which unveiled the Chocolate Touch paclitaxel DCB catheter in November 2022. This percutaneous transluminal angioplasty (PTA) catheter is explicitly designed to treat patients suffering from superficial femoral artery and popliteal artery disease. The Chocolate Touch, a drug-coated balloon, is the first of its kind to fuse the administration of a therapeutic agent with a highly advanced angioplasty platform to treat peripheral artery disease. This unique approach deploys cushion-like structures laden with a therapeutic substance to create small openings, offering an alternative therapy to the traditional drug-coated balloon angioplasty for individuals diagnosed with peripheral artery disease. Consequently, the balloon surface expands, facilitating more effective drug delivery to the vessel wall, and eliminates the need for permanent implants.

Which Segments in the Peripheral Artery Disease Market Offer the Most Profit Potential?
The peripheral artery disease market covered in this report is segmented -

1) By Type: Peripheral Angioplasty Balloons, Peripheral Stents, Peripheral Catheters, Inferior Vena Cava (IVC) Filters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices, Peripheral Accessories
2) By Drugs: Lipid-Lowering Drugs, Blood Pressure Lowering Drugs, Glucose Regulating Drugs, Blood Clot Preventing Drugs, Inotropes, Thrombolytics Agents, Anti-Inflammatory Agents
3) By Route of Administration: Oral, Parenteral, Other Routes of Administration
4) By End Users: Hospitals, Specialty Clinics, Other End Users

Subsegments:
1) By Peripheral Angioplasty Balloons: Drug-Eluting Balloons, Non-Drug-Eluting Balloons, Scoring Balloons, Cutting Balloons
2) By Peripheral Stents: Drug-Eluting Stents, Bare Metal Stents, Covered Stents
3) By Peripheral Catheters: Sheath Introducers, Guidewires, Diagnostic Catheters, Delivery Catheters
4) By Inferior Vena Cava (IVC) Filters: Retrievable IVC Filters, Permanent IVC Filters
5) By Plaque Modification Devices: Atherectomy Devices, Laser Atherectomy Devices, Rotational Atherectomy Devices
6) By Hemodynamic Flow Alteration Devices: Flow Diversion Devices, Flow Restriction Devices
7) By Peripheral Accessories: Diagnostic Imaging Accessories, Accessory Kits for Interventional Procedures, Support Devices

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=12068&type=smp

Which Firms Dominate the Peripheral Artery Disease Market by Market Share and Revenue in 2025?
Major companies operating in the peripheral artery disease market include Cardinal Health Inc., Vascular Solutions Inc., Bayer AG, Abbott Laboratories, Medtronic plc., Koninklijke Philips N.V. (Royal Philips), B. Braun Melsungen AG., Terumo Corporation, Edwards Lifesciences, Becton inson and Company (BD), Boston Scientific Corporation Incorporated, Cook Group Incorporated, Merit Medical Systems Inc., NuVasive Inc., Arjo AB, Penumbra Inc., BIOTRONIK SE and Co. KG, AngioDynamics Inc., Shockwave Medical Inc., Cardiovascular Systems Inc., Endologix LLC., LeMaitre Vascular Inc., Silk Road Medical Inc., WL Gore and Associates Inc., MicroPort Scientific Corporation, Bard Peripheral Vascular Inc., Avinger Inc.

Which Regions Offer the Highest Growth Potential in the Peripheral Artery Disease Market?
North America was the largest region in the peripheral artery disease market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the peripheral artery disease market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12068

This Report Supports:
1. Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2. Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3. Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4. Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.